QPW
RGNX icon

Quantum Private Wealth’s Regenxbio RGNX Stock Holding History

Quantum Private Wealth’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,173
Closed -$374K – 194
2022
Q3 		$374K Sell
14,173
-1,500
-10% -$44.5K 0.23% 107
2022
Q2 		$387K Sell
15,673
-2,500
-14% -$62.5K 0.23% 100
2022
Q1 		$603K Sell
18,173
-200
-1% -$5.56K 0.26% 79
2021
Q4 		$600K Buy
+18,373
New +$626K 0.23% 90

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Quantum Private Wealth's RGNX Position: Q4 2022 in Review

Quantum Private Wealth sold out of Regenxbio (RGNX) in Q4 2022, closing a stake of 14,173 shares — an estimated $374K sold.

Quantum Private Wealth first reported a position in RGNX in Q4 2021 and held it in 4 quarters. The position peaked at $603K in Q1 2022. 180 funds tracked by Wall St. Rank hold RGNX as of Q4 2022.

  • Quantum Private Wealth reported no remaining Regenxbio position as of Q4 2022 after selling out during the quarter.
  • Quantum Private Wealth sold 14,173 Regenxbio shares in Q4 2022, an estimated $374K.
  • Quantum Private Wealth first reported a position in Regenxbio in Q4 2021 and held it in 4 quarters.
  • Quantum Private Wealth's Regenxbio position peaked at $603K in Q1 2022.
  • 180 funds tracked by Wall St. Rank held Regenxbio as of Q4 2022.

Based on Quantum Private Wealth's 13F filing for Q4 2022, filed 20 Jan 2023.